Ligand validation:3LIL

HAE: ACETOHYDROXAMIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LIL_HAE_A_302	88%	3%	0.082	0.958	4.19	2.17	2	1	1	0	100%	0.872
1UTZ_HAE_A_1267	89%	49%	0.11	0.991	0.6	1.35	-	-	0	0	100%	1
5N5J_HAE_A_306	88%	29%	0.094	0.969	1.5	1.33	-	-	0	0	100%	1
1OS2_HAE_D_574	84%	2%	0.127	0.99	1.33	5.71	1	2	0	0	100%	1
3LIK_HAE_A_302	83%	4%	0.095	0.953	4.3	1.52	1	1	2	0	100%	1
2HU6_HAE_A_269	73%	63%	0.115	0.942	0.42	0.97	-	-	0	0	100%	1
6OT4_HAE_B_202	97%	7%	0.06	0.975	3.3	1.67	1	1	0	0	100%	1
4UBP_HAE_C_800	97%	53%	0.053	0.966	0.46	1.32	-	-	0	0	100%	1
1FWE_HAE_C_989	92%	59%	0.08	0.972	0.91	0.66	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.